Thirona

By Rūdolfs Latišenko

AI-powered Lung CT analysis for Respiratory Clinical Trials | Non-invasive, precise assessment of anatomical abnormalities disease progression.

In clinical studies, AI-based imaging assessment is increasingly used to support more objective evaluation of major lung disease areas such as COPD, cystic

The patent allows Thirona to develop an AI algorithm that will analyse CT scans to identify even the smallest abnormalities in the lungs, especially early on, ensuring that the right treatment can follow.

The product management team at Thirona plans and oversees releases of its AI-assisted medical image analysis products.

The Image Analysis Services team provides AI-powered medical image analysis for pulmonary clinical applications, leveraging unique segmentation technology.

Thirona integrates quality and regulatory affairs into the development of its AI-driven medical software, using certified ISO processes.

Dr. Polverino is Head of the Respiratory Infections Research Unit at Hospital Vall d’Hebron (VHIR, Barcelona), with research focused on bronchiectasis, cystic

Thirona’s Medical Advisory Board of leading pulmonology experts provides clinical guidance for AI lung imaging and personalized respiratory care.

Prof. Dr. Erik van der Heijden, MD, PhD is a pulmonary physician and research group leader of interventional pulmonology at the Radboud University Medical

Prof. Flume is a Distinguished Professor of Medicine and Pediatrics and Associate Vice President for Clinical Research at the Medical University of South

Experts in AI-powered lung image analysis with a mission to bring high-precision lung care accessible to all patients.

Thirona designs, validates, and delivers AI software solutions for lung imaging with a focus on quality, compliance, and data protection.

LungQ AI delivers quantitative analysis of thoracic CT scans, helping clinicians detect, measure and track pulmonary disease with precision.